Assessing Intratendinous Pressure and Its Correlation With Tendon Structure, Patient Characteristics, and Pain Symptoms in Individuals With and Without Midportion Achilles Tendinopathy
Assessing Intratendinous Pressure and Its Correlation With Tendon Structure, Patient Characteristics, and Pain Symptoms in Individuals With and Without Midportion Achilles Tendinopathy: An Observational Study
Study type: Observational study
Aim: To assess intratendinous pressure in individuals with and without midportion Achilles tendinopathy and investigate its correlation with tendon structure, patient characteristics, and pain symptoms.
Intervention: This is a non-interventional, observational study. Intratendinous pressure is measured using an invasive measurement method (e.g., Compass Universal Hg), used in accordance with its intended purpose.
Participants: Adults aged 18-55, both male and female, including patients with clinically diagnosed Achilles tendinopathy and healthy control participants.
Outcome measures:
-
Primary: Intratendinous pressure (mm Hg)
-
Secondary:
- Tendon structure (e.g., tendon thickness, cross-sectional area (CSA) (cm2), tendon volume (cm3) determined on ultrasound and MRI)
- Clinical outcomes (VISA-A, TENDINS-A)
- Patient characteristics (e.g., activity level, BMI, symptom duration, age,..)
Discussion: The study seeks to better understand whether intratendinous pressure is increased in symptomatic Achilles tendons compared to healthy individuals. It also examines whether there is an association with structural tendon changes, a range of patient-related factors and the clinical symptoms experienced by the patient. The findings may help refine the pathophysiological understanding of Achilles tendinopathy and support the development of future treatment strategies.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Achilles tendinopathy is a debilitating injury that is common among athletes, especially those involved in running sports. Around 30% of all runners exhibit Achilles tendinopathy with an annual incidence of 7-9%. Despite its high prevalence, the underlying pathophysiological mechanisms of Achilles tendinopathy remain incompletely understood. An emerging concept is the potential role of impaired intratendinous pressure homeostasis in the onset and progression of tendinopathy. A substantial body of in vitro and in vivo research concerning intratendinous pressure has already been conducted by Dr. Lauren Pringels, yet important knowledge gaps remain.
This observational study aims to investigate whether intratendinous pressure differs between individuals with and without Achilles tendinopathy. A secondary aim is to explore whether the intratendinous pressure correlates with tendon structure, patient characteristics, and pain symptoms.
Participants will be divided into two groups: patients clinically diagnosed with midportion Achilles tendinopathy, and asymptomatic healthy controls. The study aims to include approximately 25-30 participants per group. Participants will be recruited through sports physicians, physiotherapists, social media and study advertisements. All participants will undergo a standardized evaluation consisting of questionnaires, intratendinous pressure measurement, clinical examination and imaging assessments.
Patient-reported outcome measures will include:
- VISA-A (Victorian Institute of Sport Assessment - Achilles)
- TENDINS-A (TENDINopathy Severity Assessment - Achilles)
Patient characteristics such as age, sex, height, weight, BMI, activity level, and symptom duration will be recorded.
Intratendinous pressure measurement will be performed using a simple, directly invasive measurement method (e.g., Compass Universal Hg), in accordance with its intended clinical use. The patient is positioned prone on the examination table, with the foot supported in 30° plantar flexion. In this position, the tension on the tendon is virtually zero, representing the resting condition. The invasive measurement method is introduced under ultrasound guidance and the pressure is determined at the center of the tendon. Needle positioning is done at a 30° angle, in a distal direction and parallel to the collagen fibrils, to minimize tissue trauma.
In patients with Achilles tendinopathy, intratendinous pressure is measured at the point where the tendon is most swollen. In asymptomatic individuals, intratendinous pressure is measured at a fixed point.
Imaging assessments include B-mode ultrasound and MRI scans to assess tendon structure, including tendon thickness, cross-sectional area and tendon volume.
Studientyp
Einschreibung (Geschätzt)
Kontakte und Standorte
Studienkontakt
- Name: Lotte De Wilde
- Telefonnummer: +329 332 12 60
- E-Mail: Lotte.DeWilde@UGent.be
Studienorte
-
-
-
Ghent, Belgien, 9000
- Department of rehabilitation sciences
-
Kontakt:
- Lotte De Wilde
- Telefonnummer: +329 332 12 60
- E-Mail: Lotte.DeWilde@UGent.be
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Probenahmeverfahren
Studienpopulation
Participants will be recruited from the outpatient clinics of UZ Gent and on the UGent campus, as well as through local physiotherapy practices and orthopedic clinics in the surrounding region. Recruitment methods include distribution of flyers, social media posts and direct referrals from healthcare providers. The study population consists of adults aged 18-55 years, including individuals with clinically diagnosed midportion Achilles tendinopathy and asymptomatic healthy controls.
Beschreibung
Inclusion Criteria healthy controls:
- Participation in sports that strain the Achilles tendon (recreational or competitive) at least once a week
- Age: 18-55 y/o
Exclusion Criteria healthy controls:
- History of Achilles tendinopathy/rupture/surgery or other ankle pathology (e.g., arthritis)
- Current pain/stiffness in the Achilles tendon (VISA-A < 100)
- Underlying systemic diseases (rheumatological disorders, e.g., SpA, psoriatic arthritis; hypercholesterolemia; endocrine disorders)
- Current pregnancy
- Use of (fluoro)quinolones in the last 2 years
- Coagulation disorders
- Contraindication MRI scan
Inclusion Criteria patients with achilles tendinopathy:
- Participation in sports that strain the Achilles tendon (recreational or competitive) at least once a week
- Age: 18-55 y/o
- Duration of symptoms: > 6 weeks and < 3 years
- Midportion Achilles tendinopathy (a + b + c must be met) (a: Pain from 2.5 cm proximal to the posterosuperior calcaneal edge ; b: Pain during exercise anamnestic/single leg hop test (VAS-HOP) ; c: Ultrasound hypoechoic zones OR power Doppler signal OR increased APD)
Exclusion Criteria patients with achilles tendinopathy:
- History of Achilles tendon rupture/surgery or other ankle pathology (e.g., arthritis)
- Combination of midportion + insertional tendinopathy
- Underlying systemic diseases (rheumatological disorders, e.g., SpA, psoriatic arthritis; hypercholesterolemia; endocrine disorders)
- Current pregnancy
- Use of (fluoro)quinolones in the last 2 years ; corticosteroid injection/sclerotherapy/ESWT < 3 months ago
- Coagulation disorders
- Contraindication MRI scan
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Beobachtungsmodelle: CASE_CONTROL
- Zeitperspektiven: CROSS_SECTIONAL
Kohorten und Interventionen
Gruppe / Kohorte |
Intervention / Behandlung |
|---|---|
|
Healthy controls
Individuals without achilles tendinopathy |
Intratendinous pressure measurement will be performed using a simple, directly invasive measurement method (e.g., Compass Universal Hg), in accordance with its intended clinical use. The patient is positioned prone on the examination table, with the foot supported in 30° plantar flexion. In this position, the tension on the tendon is virtually zero, representing the resting condition. The invasive measurement method is introduced under ultrasound guidance and the pressure is determined at the center of the tendon. Needle positioning is done at a 30° angle, in a distal direction and parallel to the collagen fibrils, to minimize tissue trauma. |
|
Patients with achilles tendinopathy
Patients with midportion achilles tendinopathy |
Intratendinous pressure measurement will be performed using a simple, directly invasive measurement method (e.g., Compass Universal Hg), in accordance with its intended clinical use. The patient is positioned prone on the examination table, with the foot supported in 30° plantar flexion. In this position, the tension on the tendon is virtually zero, representing the resting condition. The invasive measurement method is introduced under ultrasound guidance and the pressure is determined at the center of the tendon. Needle positioning is done at a 30° angle, in a distal direction and parallel to the collagen fibrils, to minimize tissue trauma. |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Intratendinous pressure
Zeitfenster: Single measurement at baseline
|
Intratendinous pressure in the achilles tendon (mm Hg) |
Single measurement at baseline
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Patient reported outcome measures
Zeitfenster: Single measurement at baseline
|
VISA-A (Victorian Institute of Sport Assessment - Achilles) questionnaire ; score from 0-100 (higher score is better with 100 = no dysfunction, no pain) |
Single measurement at baseline
|
|
Patient reported outcome measures
Zeitfenster: Single measurement at baseline
|
TENDINS-A (TENDINopathy Severity Assessment - Achilles) questionnaire ; score ranging from 0-100 (higher score is worse with 0 = no dysfunction, no pain) |
Single measurement at baseline
|
|
Patient characteristics
Zeitfenster: Recorded at baseline
|
Collection of demographic and clinical variables including: age in years |
Recorded at baseline
|
|
Patient characteristics
Zeitfenster: Recorded at baseline
|
Collection of demographic and clinical variables including: sex (M/V/X) |
Recorded at baseline
|
|
Patient characteristics
Zeitfenster: Recorded at baseline
|
Collection of demographic and clinical variables including: height in cm |
Recorded at baseline
|
|
Patient characteristics
Zeitfenster: Recorded at baseline
|
Collection of demographic and clinical variables including: weight in kg |
Recorded at baseline
|
|
Patient characteristics
Zeitfenster: Recorded at baseline
|
Collection of demographic and clinical variables including: weight and height will be combined to report BMI in kg/m² |
Recorded at baseline
|
|
Patient characteristics
Zeitfenster: Recorded at baseline
|
Collection of demographic and clinical variables including: profession |
Recorded at baseline
|
|
Patient characteristics
Zeitfenster: Recorded at baseline
|
Collection of demographic and clinical variables including: physical activity level (using a 6-point likert scale) |
Recorded at baseline
|
|
Patient characteristics
Zeitfenster: Recorded at baseline
|
Collection of demographic and clinical variables including: duration of symptoms in weeks |
Recorded at baseline
|
|
Tendon structure
Zeitfenster: Single measurement at baseline
|
Assessment of tendon characteristics using ultrasound including: tendon thickness (anteroposterior diameter in cm) |
Single measurement at baseline
|
|
Tendon structure
Zeitfenster: Single measurement at baseline
|
Assessment of tendon characteristics using ultrasound including: cross-sectional area (cm²) |
Single measurement at baseline
|
|
Tendon structure
Zeitfenster: Single measurement at baseline
|
Assessment of tendon characteristics using ultrasound including: vascularity (color and power doppler signal) |
Single measurement at baseline
|
|
Tendon structure
Zeitfenster: Single measurement at baseline
|
Assessment of tendon characteristics using ultrasound including: tendon thickening (= anteroposterior diameter at thickest part of the tendon (cm) - anteroposterior diameter at 2cm proximal from calcaneal notch (cm)) |
Single measurement at baseline
|
|
Tendon structure
Zeitfenster: Single measurement at baseline
|
Assessment of tendon characteristics using MRI including: tendon volume (cm²) |
Single measurement at baseline
|
|
Tendon structure
Zeitfenster: Single measurement at baseline
|
Assessment of tendon characteristics using MRI including: T2/T2* mapping |
Single measurement at baseline
|
|
Perfusion pressure
Zeitfenster: Single measurement at baseline
|
Assessment of blood pressure to calculate perfusion pressure: ((diastolic pressure + 1/3 × [systolic pressure - diastolic pressure]) - intratendinous pressure) |
Single measurement at baseline
|
Mitarbeiter und Ermittler
Sponsor
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Andere Studien-ID-Nummern
- ONZ-2025-0357
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .